CN101053352A - Buccal tablet and its preparation method - Google Patents
Buccal tablet and its preparation method Download PDFInfo
- Publication number
- CN101053352A CN101053352A CN 200710068855 CN200710068855A CN101053352A CN 101053352 A CN101053352 A CN 101053352A CN 200710068855 CN200710068855 CN 200710068855 CN 200710068855 A CN200710068855 A CN 200710068855A CN 101053352 A CN101053352 A CN 101053352A
- Authority
- CN
- China
- Prior art keywords
- extract
- buccal tablet
- preparation
- dextrin
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940046011 buccal tablet Drugs 0.000 title claims abstract description 19
- 239000006189 buccal tablet Substances 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 32
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 23
- 239000000284 extract Substances 0.000 claims abstract description 23
- 239000004375 Dextrin Substances 0.000 claims abstract description 18
- 229920001353 Dextrin Polymers 0.000 claims abstract description 18
- 235000019425 dextrin Nutrition 0.000 claims abstract description 18
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 11
- 235000020688 green tea extract Nutrition 0.000 claims abstract description 11
- 239000001525 mentha piperita l. herb oil Substances 0.000 claims abstract description 11
- 235000019477 peppermint oil Nutrition 0.000 claims abstract description 11
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 11
- 239000011718 vitamin C Substances 0.000 claims abstract description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 4
- 238000001035 drying Methods 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims abstract description 4
- 238000003756 stirring Methods 0.000 claims abstract description 4
- 239000000080 wetting agent Substances 0.000 claims abstract description 4
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 5
- 239000007788 liquid Substances 0.000 claims description 20
- 244000269722 Thea sinensis Species 0.000 claims description 14
- 235000009569 green tea Nutrition 0.000 claims description 14
- 239000004744 fabric Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 241001571446 Scaphium scaphigerum Species 0.000 claims description 11
- 235000015165 citric acid Nutrition 0.000 claims description 10
- 235000021552 granulated sugar Nutrition 0.000 claims description 10
- 229940094952 green tea extract Drugs 0.000 claims description 9
- 241000934878 Sterculia Species 0.000 claims description 8
- 235000021282 Sterculia Nutrition 0.000 claims description 8
- 238000010438 heat treatment Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 229940059107 sterculia Drugs 0.000 claims description 8
- 239000012141 concentrate Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 239000002893 slag Substances 0.000 claims description 6
- 239000000306 component Substances 0.000 claims description 5
- 239000000945 filler Substances 0.000 claims description 5
- 239000011230 binding agent Substances 0.000 claims description 4
- 239000011669 selenium Substances 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 claims description 4
- 206010013786 Dry skin Diseases 0.000 claims description 3
- 238000000748 compression moulding Methods 0.000 claims description 3
- 239000008187 granular material Substances 0.000 claims description 3
- 229930003231 vitamin Natural products 0.000 claims description 3
- 235000013343 vitamin Nutrition 0.000 claims description 3
- 239000011782 vitamin Substances 0.000 claims description 3
- 229940088594 vitamin Drugs 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 125000003748 selenium group Chemical group *[Se]* 0.000 claims 1
- 230000036039 immunity Effects 0.000 abstract description 7
- 201000007100 Pharyngitis Diseases 0.000 abstract description 6
- 206010068319 Oropharyngeal pain Diseases 0.000 abstract description 2
- 230000036592 analgesia Effects 0.000 abstract description 2
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000001741 anti-phlogistic effect Effects 0.000 abstract 1
- 229960005070 ascorbic acid Drugs 0.000 abstract 1
- 230000004071 biological effect Effects 0.000 abstract 1
- 238000000465 moulding Methods 0.000 abstract 1
- 210000003800 pharynx Anatomy 0.000 description 20
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 230000000694 effects Effects 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 239000003814 drug Substances 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 241001570521 Lonicera periclymenum Species 0.000 description 7
- 206010000269 abscess Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 230000003110 anti-inflammatory effect Effects 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 230000036737 immune function Effects 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 244000246386 Mentha pulegium Species 0.000 description 3
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 3
- 241000194017 Streptococcus Species 0.000 description 3
- 208000017574 dry cough Diseases 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 206010020718 hyperplasia Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000036407 pain Effects 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 210000003371 toe Anatomy 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 229920002245 Dextrose equivalent Polymers 0.000 description 2
- 206010013789 Dry throat Diseases 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 235000016257 Mentha pulegium Nutrition 0.000 description 2
- 235000004357 Mentha x piperita Nutrition 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 229950001002 cianidanol Drugs 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000002949 hemolytic effect Effects 0.000 description 2
- 235000001050 hortel pimenta Nutrition 0.000 description 2
- 210000002751 lymph Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- -1 stir Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- LOTKRQAVGJMPNV-UHFFFAOYSA-N 1-fluoro-2,4-dinitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C([N+]([O-])=O)=C1 LOTKRQAVGJMPNV-UHFFFAOYSA-N 0.000 description 1
- 239000001169 1-methyl-4-propan-2-ylcyclohexa-1,4-diene Substances 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000208828 Caprifoliaceae Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 206010018691 Granuloma Diseases 0.000 description 1
- 201000006219 Herpangina Diseases 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- XMLSXPIVAXONDL-PLNGDYQASA-N Jasmone Chemical compound CC\C=C/CC1=C(C)CCC1=O XMLSXPIVAXONDL-PLNGDYQASA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 201000008197 Laryngitis Diseases 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 241001119048 Luscinia pectardens Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 206010025280 Lymphocytosis Diseases 0.000 description 1
- 241000219071 Malvaceae Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 240000001307 Myosotis scorpioides Species 0.000 description 1
- 206010028665 Myxoedema Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 241000588769 Proteus <enterobacteria> Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241001122767 Theaceae Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000016150 acute pharyngitis Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 239000010692 aromatic oil Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 229960000074 biopharmaceutical Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 description 1
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 description 1
- 235000007746 carvacrol Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001886 ciliary effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000002478 diastatic effect Effects 0.000 description 1
- YXUPZGKORWTXID-UHFFFAOYSA-N domiphen Chemical compound CCCCCCCCCCCC[N+](C)(C)CCOC1=CC=CC=C1 YXUPZGKORWTXID-UHFFFAOYSA-N 0.000 description 1
- 229960000629 domiphen Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 241001233957 eudicotyledons Species 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 210000002683 foot Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 150000002729 menthone derivatives Chemical class 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000003786 myxedema Diseases 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 210000003300 oropharynx Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000007875 phellandrene derivatives Chemical class 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000902 placebo Substances 0.000 description 1
- 229940068196 placebo Drugs 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003507 refrigerant Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 150000003384 small molecules Chemical class 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 108700024661 strong silver Proteins 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- XMLSXPIVAXONDL-UHFFFAOYSA-N trans-jasmone Natural products CCC=CCC1=C(C)CCC1=O XMLSXPIVAXONDL-UHFFFAOYSA-N 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a buccal tablet and its preparation method, in order to reduce the incidence probability of sore throat, composed of green tea extracts, saphium lychnophorum extracts, honeysuckle extracts, peppermint oil, vitamin c, sugar, dextrin and citric acid, its preparation method is that preparing green tea extracts, saphium lychnophorum extracts, honeysuckle extracts respectively, adding sugar, dextrin vitamin C and citric acid, with 60 percent (volume ratio) edible alcohol as wetting agent, stirring uniform, granulating, adding peppermint oil 20 to 100 and mixing after drying at 50 to 60 DGE C, compacting and moulding. It is scientific composing prescription, can not only be antiphlogistic and analgesia, but also enhance human body immunity, simple, fast and convenient, can preserve biological activity of various extracts maximum.
Description
Technical field
The present invention relates to a kind of buccal tablet, especially relate to a kind of buccal tablet Chinese medicine and green tea composition, that have the pharynx-clearing throat-benefiting function that contains.
Background technology
Abscess of throat (sore throat) is oropharynx and a kind of clinical symptoms of laryngopharynx portion pathology, all suffer from acute or chronic pharyngitis, laryngitis, tonsillitis, circumtonsillar abscess, herpangina, ulceromembranous pharyngitis, throat abscess etc., all can cause the bottleneck throat congestion and swelling pain, swallow discomfort, claim again " larynx numbness ".Doctor trained in Western medicine generally believes it is by bacterial disease, the general local application that pays attention to combines the method for getting with antibiotic in treatment, as with 2% canopy acid solution, 3% salt solution and 1: 5000 furacilin solution be rinse repeatedly, perhaps use 2% jodine glycerin, 5% protargol liquid way in pharynx wall, or be contained in the oral cavity etc. with tabellae iodi gurgitis, Domiphen, peppermint etc., the function of certain relief of symptoms is arranged.China's traditional medicine is thought, abscess of throat is the heresy by affection of exogenous wind-heat mostly, or because of lung stomach stagnated fire upper punch, or by due to fire excess from yin deficiency, generally take to make up a prescription to the ill, take preparation, or take Chinese patent drug according to disease, but abscess of throat is a common frdquently encountered disease disease, seeking the dialectical preparation that makes up a prescription of doctor is a comparatively complicated process, patient treatment efficient is low, and doctor trained in Western medicine is too frequently measured and can be caused certain infringement to human body greatly eventually because use antibiotic, and incidence of disease height; Existing medical expert has appealed that the doctor changes treatment idea and the methods of treatment of traditional pharyngolaryngitis as the inflammation that swells and ache etc., not once finding that inflammation uses antibiotic, to reduce the side effect that antibiotic brings.
Summary of the invention
Purpose of the present invention mainly is that solution existing in prior technology therapeutic efficiency is not high, and uses antibiotic to the prejudicial technical problem of human body; Another object of the present invention is under the prerequisite of setting up the active treatment medical model, a kind of effectively anti-inflammatory analgesic is provided, be aided with buccal tablet that improves the body immunity effect and preparation method thereof simultaneously, make the treatment of this class common frdquently encountered disease disease of abscess of throat more simple and effective, reduce incidence probability.
Above-mentioned technical problem of the present invention is mainly solved by following technical proposals: buccal tablet is made by functional component, filler, binding agent, acidity regulator, wherein functional component is green-tea extract, Scaphium scaphigerum extract, Honegsukle flower P.E, peppermint oil and vitamin C, wherein honeysuckle is the close honeysuckle flower that adopts Xinmi City, Henan to produce, filler is a white granulated sugar, binding agent is a dextrin, acidity regulator is a citric acid, and concrete proportion of composing is counted by weight:
Green tea 500~1000 (the extract dry product is 75~150)
The sterculia seed 600~1200 (the extract dry product is 60~100)
Honeysuckle 200~600 (the extract dry product is 20~60)
Peppermint oil 20~100 Catergens 5~150 white granulated sugars 100~500
Dextrin 100~400 citric acids 20~70
The preparation method of buccal tablet is:
A: get green tea and put the water retting 0.5~1.5 hour that adds 10~15 times in the extractor, heating is boiled and was kept 1 hour, obtains decocting liquid one time, filters through 100~200 mesh sieve cloth; Be heated to and boil 1~1.5 hour frying in shallow oil water that slag adds 3~5 times, get the secondary decocting liquid, filter through 100~200 mesh sieve cloth, twice decocting liquid merging left standstill, get the upper strata stillness of night and send in the concentration tank, under atmospheric pressure state, be concentrated into relative density 1.15~1.25, require 85~90Kpa, temperature dry under 65 ℃~80 ℃ conditions in vacuum concentrate, pulverize, through 80 orders sieve green-tea extract;
B: get the clean sterculia seed and place the water retting 0.5~1 hour that adds 5~10 times in the extractor, heating is boiled and was kept 2 hours, obtains decocting liquid one time, filters through 80~200 mesh sieve cloth; Be heated to and boil 1~1.5 hour frying in shallow oil water that slag adds 3~5 times, get the secondary decocting liquid, filter through 100~200 mesh sieve cloth, twice decocting liquid merging left standstill, get the upper strata stillness of night and send in the concentration tank, under atmospheric pressure state, be concentrated into relative density 1.15~1.25, require 85~90Kpa, temperature dry under 65 ℃~80 ℃ conditions in vacuum concentrate, pulverize, through 80 orders sieve Scaphium scaphigerum extract;
C: Honegsukle flower P.E is identical with the Scaphium scaphigerum extract method;
D: white granulated sugar is crushed to 80~120 orders, in addition dextrin, vitamin C, citric acid is crushed to 60~100 orders respectively;
E: get green-tea extract, Scaphium scaphigerum extract, Honegsukle flower P.E, white granulated sugar, dextrin, vitamin C, citric acid by prescription, the edible alcohol that adds 60% (volume %) is as wetting agent, stir, granulate, after 50 ℃~60 ℃ dryings, add peppermint oil 20~100 mixings, compression moulding.
As preferably, green tea adopts selenium-rich green tea.
Below to prescription of the present invention according to elaborating:
Green tea: be the bud of Theaceae plant tea tree, leaf, tender stem, contain Tea Polyphenols in the tealeaves, catechin (EGCG), vitamin C and vitamin E, the phenols thing that spreads out, aromatic substance, amino acids material etc., also contain and enrich inorganic anticancer element, mainly contain selenium, molybdenum, manganese, germanium etc., can play nutrition health-care functions to human body, trace element in the tealeaves, material such as vitamin and Tea Polyphenols can suppress bacterium, removes free radical, suppress lipid peroxidation, also has the raising immunologic function, antitumor, reducing blood lipid, prevent effects such as atherosclerotic, result of the test shows, the tealeaves antistaphylohemolysin, streptococcus, Pseudomonas aeruginosa, proteus, shigella dysenteriae, Escherichia coli, effect obviously, in addition, the catechin of green tea has directly short proliferation function to lymphocyte, can obviously strengthen the NK cytoactive simultaneously, and green-tea extract can obviously suppress the mouse ear skin that TPA induces and produce red and swollen inflammatory reaction.In addition, more obvious as preferred selenium-rich green tea for the more common green tea of effect that improves body immunity.
The sterculia seed: be the mature seed of the Sterculiaceae plant sterculia seed, contain galacturonic acid, arabinose, galactolipin acetate, galactolipin, sterculin (sterculin), tragacanth sticking plain (bassorin) etc.Cold in nature, it is sweet, light to distinguish the flavor of.Energy clearing lung-heat heat, throat, gut purge defaecation.The traditional Chinese medical science is used for dry cough without phlegm, pharyngalgia hoarsen, chronic pharyngitis, constipation with heat retention more.Prove that through modern scientific research the sterculia seed has tangible anti-inflammatory, bactericidal action, can also increase mouse thymus weight and spleen weight, specific immune function is had facilitation.
Honeysuckle: be the caprifoliaceae plant dry flower of honeysuckle, the cold virtue clearly of Yin Qigan has clearing heat and detoxicating, effects such as detumescence makes eye bright, expelling wind and cold pathogens, also has in the appetizing again, the effect that detoxifcation is relieved inflammation or internal heat, the traditional Chinese medical science is used for controlling warm disease heating, temperature bloody flux, large carbuncle, pyogenic infections etc. more.Doctor trained in Western medicine studies have shown that have resisting pathogenic microbes, anti-inflammatory is analgesic, improve effects such as immunologic function.1200 meters of the five fingers mountain range, point mountain, Xinmi City, Henan, close honeysuckle flower original producton location described in the present invention , Hai order.Honeysuckle includes wooden slippers straw colour element, inositol, biologicals such as tannic acid, go back protogene in a large number because of containing, so to staphylococcus, hemolytic streptococcus, typhoid bacillus, in conjunction with bacillus, pneumococcus, the toxin of secretions such as Escherichia coli has inhibitory action, macrophage phagocytic function is significantly improved, low macrophage antigen function is restored, pharmacological testing proof Honegsukle flower P.E can obviously reduce the swollen weight of rat granuloma, increase the phenol red excretion amount of mouse tracheae, and the ciliary movement of rabbit tracheae had obvious facilitation, at anti-inflammatory, the aspect of reducing phlegm effect is obvious.
Peppermint oil, English name PeppermintOil, for the bright cauline leaf of dicotyledon medicine Labiatae research plant peppermint or tame peppermint through distillable aromatic oil.For colourless oily liquids to faint yellow or green-yellow, pungent and refrigerant, strong scurrying property is arranged.Contain menthol (alcohols), thin what ester of acetic acid, carvone, jasmone, menthones, carvacrol, citrene, phellandrene etc., pungent in flavor and cool in property, return lung, Liver Channel, have the effect of wind and heat dispersing, can suppress the mucous membrane inflammation, eliminate implication, relieveing pain and refreshing.The evidence mint extract reacts to the rat carrageenan foot swelling, to the mouse acetic acid twisting all inhibitory action in various degree.Menthol has analgesia and antiinflammation.To staphylococcus aureus, beta hemolytic streptococcus, pneumococcus, corynebacterium diphtheriae, inhibitory action is arranged, dinitrofluorobenzene induced mice delayed allergy is not had obvious influence, think that these product have obviously antibacterial, anti-granulation hyperplasia, resolve phlegm effect.
Vitamin C: have height reducing substances and have oxidation resistant physiological action, be safeguard that body health promotes to grow with regulate the necessary organic compound of physiological function, strengthening immunologic function, promoting mineral matter element to absorb and promote playing an important role aspect the wound healing.Adding the vitamin purpose among the present invention is to improve body immunity, helps the function of moistening and cleaning throat of product better to bring into play.
Dextrin: English name Dextrin is to be raw material with starch, is being subjected to carrying out low in hydrolysis under heating, acid or the diastatic action, macromolecular starch at first transforms into micromolecular intermediate material, at this moment middle small-molecule substance, its dextrose equivalent (DE)<20%, people just are called dextrin to it.Dextrin is the amorphous powder of white or off-white color, odorless, it is little sweet to distinguish the flavor of, and mainly as the filler of tablet, has good brew in pharmaceuticals industry, instant effective, taste just, thickening and emulsify well.Can well change properties of product, improve the quality of products.In the present invention, dextrin one is to use as bond, adhesive, can improve ratio of briquetting, in the shortening cycle, increases work efficiency; The 2nd, as stabilizing agent, dextrin toughness height, stability is also high.
The inventor thinks that bottleneck throat directly communicates with nature, all there is bacterium to exist under the normal condition, because of physics, chemical irritation or immunity degradation, bottleneck throat germ reproduction and causing a disease, bottleneck throat hyperemia, oedema, lymph foilicie hyperplasia appear, disease sees that pharynx is ached, itches, done, foreign body sensation etc., it is common frdquently encountered disease disease, therefore, should be to put prevention first, anti-inflammatory is loose bitterly on the one hand, on the one hand by improving body immunity, twice combinations are with the purpose that reaches the training source that consolidates, preventing and treating diseases, improves health conditions.For the affection of exogenous wind-heat type, the wind heat-clearing thereby product of the present invention can loose, secretion replenishing and throat moistening swelling and pain relieving; For lung stomach excess pattern of fever, product of the present invention clearly purging the lung of pathogenic fire heat with stomach fire, fire falls with yin-nourishing, decrease in interior for lung-kidney deficiency, lung kidney essense gas consumption, the throat illness of flaring up of deficient fire throat type, but the present invention's heat-clearing is moistened throat with yin-nourishing thereby go up, fall fiery anti-inflammatory, eliminate abscess of throat.
Therefore, the present invention has the prescription science, but both anti-inflammatory analgesics can improve body immunity again, strengthens resistance against diseases, and its method is simple and efficient, can keep characteristics such as each extract biologically active to greatest extent.
The specific embodiment
Below by embodiment, technical scheme of the present invention is described in further detail.
Embodiment: a: get 1000 portions of green tea and put the water retting 0.5 hour that adds 10 times in the extractor, heating is boiled and was kept 1 hour, obtains decocting liquid one time, filters through 100 mesh sieve cloth; Be heated to and boil 1 hour frying in shallow oil water that slag adds 3 times, get the secondary decocting liquid, filter through 120 mesh sieve cloth, twice decocting liquid merging left standstill, get the upper strata stillness of night and send in the concentration tank, under atmospheric pressure state, be concentrated into relative density 1.25, require 87Kpa, temperature dry under 65 ℃ of conditions in vacuum concentrate, pulverize, through 80 orders sieve green-tea extract;
B: get the clean sterculia seed and place the water retting 0.5 hour that adds 5 times in the extractor for 1000 parts, heating is boiled and was kept 2 hours, obtains decocting liquid one time, filters through 80 mesh sieve cloth; Be heated to and boil 1.5 hours frying in shallow oil water that slag adds 5 times, get the secondary decocting liquid, filter through 120 mesh sieve cloth, twice decocting liquid merging left standstill, get the upper strata stillness of night and send in the concentration tank, under atmospheric pressure state, be concentrated into relative density 1.25, require 87Kpa, temperature dry under 65 ℃ of conditions in vacuum concentrate, pulverize, through 80 orders sieve Scaphium scaphigerum extract;
C: Honegsukle flower P.E is identical with Scaphium scaphigerum extract consumption and method in this example;
D: white granulated sugar is crushed to 80 orders, in addition dextrin, vitamin C, citric acid is crushed to 60 orders respectively;
E: get green-tea extract, Scaphium scaphigerum extract, Honegsukle flower P.E, white granulated sugar, dextrin, vitamin C, citric acid by prescription, the edible alcohol that adds 60% (volume %) is as wetting agent, stir, granulate, after 60 ℃ of dryings, add peppermint oil 20 mixings, by every 0.5g compression moulding.
Product of the present invention is carried out animal experiment, set up basic, normal, high three dosage groups, 5,10,15 times of using the human body RD respectively, animal used as test is a cleaning level SD rat, and per os is given clothes 30 days continuously, and the 31st day once more to clothes, after causing inflammation, it is as follows to record data:
Buccal tablet is to the influence of animal toes thickness
Dosage | Size of animal (only) | Animal toes thickness (mm) | |||
Before causing inflammation | Cause scorching back 1 hour | Cause scorching back 3 hours | Cause scorching back 6 hours | ||
0.00g/kg | 10 | 4.18±0.42 | 6.26±0.38 | 7.22±0.23 | 6.89±0.28 |
0.25g/kg | 10 | 4.13±0.27 | 6.1 5±0.26 | 7.03±0.45 | 6.93±0.36 |
0.50g/kg | 10 | 4.14±0.28 | 5.76±0.27 | 6.54±0.29 | 6.44±0.25 |
1.50g/kg | 10 | 4.17±0.26 | 5.56±0.30 | 6.29±0.26 | 6.18±0.28 |
Experimental result shows: buccal tablet of the present invention can obviously alleviate animal and cause 1,3, the 6 hour toes swelling degree in scorching back.
Product of the present invention is carried out human feeding trial, adopt the double blind control method, with 103 routine experimenters, clinical symptoms, pharyngeal sign are divided into test-meal group 51 examples and control group 52 examples at random, take buccal tablet and placebo respectively, every day 3 times, each 2.After 15 days, observed and recorded result, improvement rate X
2Check, calculate the back and obtain following data:
Pharyngeal clinical symptoms is improved situation | ||
Symptom | Control group improvement rate | Test-meal group improvement rate |
Pharyngalgia | 27.27 | 69.57 |
Pharynx is itched | 25.00 | 72.73 |
Dry throat | 37.50 | 72.00 |
Dry cough | 33.33 | 71.43 |
Foreign body sensation | 38.46 | 58.33 |
Many speeches increase the weight of | 40.00 | 60.00 |
Pharyngeal sign is improved situation | ||
Symptom | Control group improvement rate | Test-meal group improvement rate |
Myxedema | 15.00 | 54.55 |
Mucous hyperemia | 26.00 | 65.31 |
Lymphocytosis | 26.67 | 64.52 |
Secretion adheres to | 25.00 | 57.14 |
The result shows, buccal tablet to pharyngalgia, pharynx itch, dry throat, dry cough, foreign body sensation, many speeches increase the weight of etc., and pharyngeal clinical symptoms has clear improvement, pharyngeal signs such as lymph foilicie hyperplasia, secretion after pharyngeal mucosa oedema, mucous hyperemia, the pharynx adhere to are had clear improvement.
At last, should be pointed out that above embodiment only is the more representational example of the present invention.Obviously, technical scheme of the present invention is not limited to the foregoing description, and many distortion can also be arranged.All distortion that those of ordinary skill in the art can directly derive or associate from content disclosed by the invention all should be thought protection scope of the present invention.
Claims (3)
1. buccal tablet and preparation method thereof, described buccal tablet is made by functional component, filler, binding agent, acidity regulator, it is characterized in that described functional component is green-tea extract, Scaphium scaphigerum extract, Honegsukle flower P.E, peppermint oil and vitamin C, wherein said honeysuckle is the close honeysuckle flower that adopts Xinmi City, Henan to produce, described filler is a white granulated sugar, described binding agent is a dextrin, described acidity regulator is a citric acid, and described buccal tablet is counted by weight by following component and formed:
Green tea 500~1000 (the extract dry product is 75~150)
The sterculia seed 600~1200 (the extract dry product is 60~100)
Honeysuckle 200~600 (the extract dry product is 20~60)
Peppermint oil 20~100 vitamin Cs 25~150 white granulated sugars 100~500
Dextrin 100~400 citric acids 20~70.
2. a kind of buccal tablet according to claim 1 and preparation method thereof is characterized in that the preparation method of described buccal tablet comprises following steps:
A: get green tea and put the water retting 0.5~1.5 hour that adds 10~15 times in the extractor, heating is boiled and was kept 1 hour, obtains decocting liquid one time, filters through 100~200 mesh sieve cloth; Be heated to and boil 1~1.5 hour frying in shallow oil water that slag adds 3~5 times, get the secondary decocting liquid, filter through 100~200 mesh sieve cloth, twice decocting liquid merging left standstill, get the upper strata stillness of night and send in the concentration tank, under atmospheric pressure state, be concentrated into relative density 1.15~1.25, require 85~90Kpa, temperature dry under 65 ℃~80 ℃ conditions in vacuum concentrate, pulverize, through 80 orders sieve green-tea extract;
B: get the clean sterculia seed and place the water retting 0.5~1 hour that adds 5~10 times in the extractor, heating is boiled and was kept 2 hours, obtains decocting liquid one time, filters through 80~200 mesh sieve cloth; Be heated to and boil 1~1.5 hour frying in shallow oil water that slag adds 3~5 times, get the secondary decocting liquid, filter through 100~200 mesh sieve cloth, twice decocting liquid merging left standstill, get the upper strata stillness of night and send in the concentration tank, under atmospheric pressure state, be concentrated into relative density 1.15~1.25, require 85~90Kpa, temperature dry under 65 ℃~80 ℃ conditions in vacuum concentrate, pulverize, through 80 orders sieve Scaphium scaphigerum extract;
C: Honegsukle flower P.E is identical with the Scaphium scaphigerum extract method;
D: white granulated sugar is crushed to 80~120 orders, in addition dextrin, vitamin C, citric acid is crushed to 60~100 orders respectively;
E: get green-tea extract, Scaphium scaphigerum extract, Honegsukle flower P.E, white granulated sugar, dextrin, vitamin C, citric acid by prescription, the edible alcohol that adds 60% (volume %) stirs as wetting agent, granulate, after 50 ℃~60 ℃ dryings, add the peppermint oil mixing, compression moulding.
3. a kind of buccal tablet according to claim 1 and 2 and preparation method thereof, the green tea that it is characterized in that described preparation buccal tablet is selenium-rich green tea.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100688558A CN101053352B (en) | 2007-05-22 | 2007-05-22 | Buccal tablet and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2007100688558A CN101053352B (en) | 2007-05-22 | 2007-05-22 | Buccal tablet and its preparation method |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101053352A true CN101053352A (en) | 2007-10-17 |
CN101053352B CN101053352B (en) | 2011-09-14 |
Family
ID=38793552
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2007100688558A Active CN101053352B (en) | 2007-05-22 | 2007-05-22 | Buccal tablet and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101053352B (en) |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102308939A (en) * | 2011-07-21 | 2012-01-11 | 宁国市亿邦生物科技有限公司 | Litsea coreana sugar-free buccal tablet |
CN101690531B (en) * | 2009-10-13 | 2013-02-27 | 夏海龙 | Fire-clearing cold-dispelling tea |
CN103315292A (en) * | 2013-05-20 | 2013-09-25 | 安徽天方茶业(集团)有限公司 | Selenium-rich tea buccal tablets and preparation method thereof |
CN103431098A (en) * | 2013-09-11 | 2013-12-11 | 江苏丘陵地区镇江农业科学研究所 | Method for preparing okra tea lozenges |
CN103907717A (en) * | 2014-03-31 | 2014-07-09 | 吴淑芬 | Method for preparing green tea dew |
CN105028864A (en) * | 2015-06-30 | 2015-11-11 | 朱丹 | Dark tea extract buccal tablets and preparation method thereof |
CN106177190A (en) * | 2016-08-15 | 2016-12-07 | 新疆环拓生物科技有限公司 | A kind of guttural tablets and preparation method thereof |
CN106804816A (en) * | 2017-01-16 | 2017-06-09 | 广州大浦金医药科技有限公司 | Tea buccal tablet and preparation method thereof |
CN107125616A (en) * | 2017-04-26 | 2017-09-05 | 合肥绿益食品有限公司 | Beef ham is hyperchromic and color protecting method |
CN107897422A (en) * | 2017-12-06 | 2018-04-13 | 浙江东来药业有限责任公司 | A kind of enzyme tea buccal tablet for protecting oral hygiene and preparation method thereof |
CN108684915A (en) * | 2018-04-03 | 2018-10-23 | 温州科技职业学院 | A kind of yellow tea sugar-free low energy is without matrix chewing gum and preparation method thereof |
CN111616365A (en) * | 2020-07-03 | 2020-09-04 | 广州市博卡利生物科技研究所 | Preparation method of refreshing liquid acting on central nerves |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1290424C (en) * | 2005-05-26 | 2006-12-20 | 浙江大学 | Quickly dissolving tea paste, and its processing art |
-
2007
- 2007-05-22 CN CN2007100688558A patent/CN101053352B/en active Active
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101690531B (en) * | 2009-10-13 | 2013-02-27 | 夏海龙 | Fire-clearing cold-dispelling tea |
CN102308939A (en) * | 2011-07-21 | 2012-01-11 | 宁国市亿邦生物科技有限公司 | Litsea coreana sugar-free buccal tablet |
CN103315292A (en) * | 2013-05-20 | 2013-09-25 | 安徽天方茶业(集团)有限公司 | Selenium-rich tea buccal tablets and preparation method thereof |
CN103431098A (en) * | 2013-09-11 | 2013-12-11 | 江苏丘陵地区镇江农业科学研究所 | Method for preparing okra tea lozenges |
CN103907717A (en) * | 2014-03-31 | 2014-07-09 | 吴淑芬 | Method for preparing green tea dew |
CN103907717B (en) * | 2014-03-31 | 2015-10-14 | 桂林融通科技有限公司 | A kind of preparation method of green tea dew |
CN105028864A (en) * | 2015-06-30 | 2015-11-11 | 朱丹 | Dark tea extract buccal tablets and preparation method thereof |
CN105028864B (en) * | 2015-06-30 | 2018-10-30 | 朱丹 | A kind of black tea extract buccal tablet and preparation method thereof |
CN106177190A (en) * | 2016-08-15 | 2016-12-07 | 新疆环拓生物科技有限公司 | A kind of guttural tablets and preparation method thereof |
CN106804816A (en) * | 2017-01-16 | 2017-06-09 | 广州大浦金医药科技有限公司 | Tea buccal tablet and preparation method thereof |
CN107125616A (en) * | 2017-04-26 | 2017-09-05 | 合肥绿益食品有限公司 | Beef ham is hyperchromic and color protecting method |
CN107897422A (en) * | 2017-12-06 | 2018-04-13 | 浙江东来药业有限责任公司 | A kind of enzyme tea buccal tablet for protecting oral hygiene and preparation method thereof |
CN108684915A (en) * | 2018-04-03 | 2018-10-23 | 温州科技职业学院 | A kind of yellow tea sugar-free low energy is without matrix chewing gum and preparation method thereof |
CN111616365A (en) * | 2020-07-03 | 2020-09-04 | 广州市博卡利生物科技研究所 | Preparation method of refreshing liquid acting on central nerves |
Also Published As
Publication number | Publication date |
---|---|
CN101053352B (en) | 2011-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101053352B (en) | Buccal tablet and its preparation method | |
CN101708229B (en) | Oral tablet and preparation method thereof | |
CN101040950B (en) | Method of preparing compound Houttuynia cordata dropping pills | |
CN104434690A (en) | Mouthwash and preparation method thereof | |
CN1861102A (en) | Tablets for promoting prodn. of body-fluid and nourishing throat | |
CN1827146A (en) | Health-caring food for preventing and treating acute and chronic laryngopharyngitis and method for preparing the same | |
CN106177190A (en) | A kind of guttural tablets and preparation method thereof | |
CN1907374A (en) | Chinese medicinal composition for treating oral disease | |
CN101406629A (en) | Buccal tablets for treating painful swelling of gingiva and preparation method thereof | |
KR101958969B1 (en) | A composition for improving, preventing and treating of alcoholic gastrointestinal diseases comprising a complex extract of seaweed and complex extract of plant | |
CN103520287B (en) | Forsythia suspense leaves refreshing sugar | |
CN109481544A (en) | A kind of preventing phlegm from forming and stopping coughing lozenge and preparation method thereof | |
CN104491372A (en) | Radix scrophulariae buccal tablet | |
CN102028798A (en) | Traditional Chinese medicine composite for treating respiratory disease of livestock and poultry | |
CN106361805A (en) | Traditional Chinese medicine composition with throat clearing effect, and preparation method and preparation thereof | |
CN1353977A (en) | Chinese herbal medicine floral water and its production process | |
CN100998690A (en) | Traditional Chinese medicine detoxification preparation and its preparing method | |
CN107213351B (en) | Dendrobium nobile buccal tablet and preparation method thereof | |
CN100542413C (en) | Bear bile tea and preparation method thereof | |
CN109893641A (en) | A kind of immediate access ginger powder and preparation method thereof with throat-clearing throat-moistening function | |
CN1163116A (en) | Compound health medicinal emblic tablet and its producing technology | |
CN1422655A (en) | Throat lozenge | |
CN116036174B (en) | Medicine for treating pulmonary nodules and preparation method thereof | |
CN108420905A (en) | A kind of prevention stomatitis and pharyngitis oil tea and preparation method thereof | |
CN108938720A (en) | A kind of Chinese medicine and preparation method thereof for treating diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20071017 Assignee: Fujian green tea Limited by Share Ltd Assignor: Zhejiang University Contract record no.: 2013330000033 Denomination of invention: Buccal tablet and its preparation method Granted publication date: 20110914 License type: Exclusive License Record date: 20130319 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model |